Filing metadata

Accession number
0001209191-22-037521
Form type
Form 3
Filer
Tvardi Therapeutics, Inc.
CIK
CIK 1346830
Filed
Jun 16, 2022
Reporting period
Jun 15, 2022
Description
Initial ownership

Explore SEC Filings Hub